Patent Litigation in the United Kingdom in 2026, Forum Choice, Cost Strategy and Enforcement After UKIPO Fee Rises

Executive Summary and Quick Decisions

For any general counsel or patent owner weighing whether to enforce or defend a patent in the United Kingdom in 2026, the answer remains emphatically yes, the UK courts continue to offer world-class patent litigation, with experienced specialist judges, powerful injunctive remedies and proceedings that move faster than many comparable jurisdictions. What has changed is the cost calculus. The UKIPO fee increases that took effect on 1 April 2026, raising official filing, examination and renewal charges by an average of roughly 25%, mean that every strategic decision, from forum selection to claim drafting, now carries a materially higher price tag. Getting those decisions right at the outset has never been more important.

The five tactical takeaways that every rights-holder and defendant should act on immediately are:

• Choose the right forum first. The gap in cost and procedural intensity between IPEC and the Patents Court (High Court) is wide, and picking the wrong venue wastes budget that the 2026 fee changes have already tightened.
• Audit renewal and prosecution pipelines now. Higher UKIPO renewal fees compound over a portfolio’s lifetime; early rationalisation of marginal patents frees budget for enforcement of core assets.
• Coordinate UK and EPO routes before issuing proceedings. An EPO opposition can centrally revoke a patent across all EPC member states, but it cannot enforce rights or obtain an injunction, sequencing matters.
• Model damages early. A realistic damages estimate at the pre-action stage drives every downstream decision, from IPEC eligibility to funding structures.
• Build ADR triggers into the litigation plan. Mediation and early neutral evaluation can cap exposure before the heaviest disclosure and trial-preparation costs are incurred.

The sections that follow provide the detailed decision frameworks, comparison tables, cost examples and checklists needed to implement each of these priorities in the current UK patent litigation landscape.

What Changed in 2026: UKIPO Fee Rises and Regulatory Signals

On 1 April 2026, the UK Intellectual Property Office increased fees for patents, trade marks and registered designs, the first significant patent fee rise in many years. According to the official GOV.UK notice published on 12 March 2026, the government confirmed that fees would rise by an average of 25% across all IP rights, although individual fee lines vary. For patent owners and litigants, the practical effect is a meaningful increase in the cost of obtaining, maintaining and challenging UK patent rights.

Fee Types Affected: Filing, Search, Examination, Renewals and Excess Claims

The 2026 changes touch virtually every stage of the patent lifecycle at the UKIPO. Online patent application filing fees, combined search and examination fees, and annual renewal fees from the fifth year onward have all been raised. Excess claims fees, charged where an application exceeds 25 claims, and excess page fees have also increased. For parties involved in UKIPO proceedings (such as opinions under section 74A of the Patents Act 1977, or entitlement disputes), official fees for initiating and responding to those procedures have risen in line with the broader schedule.

Industry observers expect these increases to have a compounding effect on large portfolios. A multinational maintaining 50 UK patents will see cumulative renewal costs rise by tens of thousands of pounds over a five-year horizon. For SMEs with tighter budgets, the increases create pressure to rationalise portfolios earlier and more aggressively, potentially allowing valuable patents to lapse if cost-benefit analysis is not conducted rigorously.

Practical Impact Examples: SME vs Multinational

Two worked scenarios illustrate how the fee changes translate into real-world budget decisions for patent prosecution and enforcement. The table below compares indicative official UKIPO costs before and after 1 April 2026 for a representative filing-through-grant cycle and a mid-portfolio renewal position.

These figures cover official fees only and exclude professional adviser costs, which remain the largest component of total expenditure. Nonetheless, the direction is clear: every aspect of UK patent litigation must now factor in higher baseline costs for the underlying rights being litigated. Practitioners at leading firms have noted that clients should review their prosecution pipelines and, where filings or renewals are already contemplated, consider whether accelerating actions before fee-change dates for future increases can yield meaningful savings.

Forum Choice: IPEC vs Patents Court, Patent Litigation UK Decision Tree

The single most consequential decision in UK patent litigation is choosing whether to bring proceedings in the Intellectual Property Enterprise Court (IPEC) or the Patents Court, a specialist list within the Business and Property Courts of England and Wales (High Court). The right answer depends on a matrix of factors, claim value, technical complexity, desired remedies, cost appetite and speed, and the 2026 UKIPO fee changes sharpen the need to get this choice right from day one.

IPEC: Strengths, Limits, Timeline and Cost Drivers

IPEC was designed to provide a proportionate, lower-cost forum for intellectual property disputes that do not justify the full-scale machinery of the High Court. The revised IPEC Guide, published by the judiciary in November 2024, sets out the court’s two tracks: the multi-track (for claims of moderate value and complexity) and the small claims track (for straightforward disputes with lower financial stakes). Key features that drive forum-selection decisions include:

• Damages cap. IPEC imposes a £500,000 cap on damages and a £25,000 cap on costs recovery, making it unsuitable for high-value claims but highly attractive for disputes where proportionality is paramount.
• Streamlined procedures. Disclosure is limited, trials are shorter (typically one to two days on the multi-track), and case management is tighter, with active judicial control from an early stage.
• Speed. Cases on the multi-track can often reach trial within 12 months of issue. The small claims track can be faster still.
• Injunctions. IPEC can grant final injunctions, which for many rights-holders are the primary objective of enforcement.

The likely practical effect of the 2026 fee environment is that IPEC will see increased demand from SMEs and mid-cap companies seeking to enforce or defend patent rights without committing to the open-ended cost profile of the Patents Court.

Patents Court: Strengths, Remedies, Interlocutory Relief and Discovery

The Patents Court, part of the Chancery Division of the High Court, handles the most complex and high-value patent disputes in England and Wales. It offers the full range of remedies: final and interim injunctions, damages or (at the claimant’s election) an account of profits, declarations of non-infringement, and orders for delivery up or destruction of infringing goods. Anton Piller (search) orders and freezing injunctions are available in appropriate cases. Full disclosure, including standard and specific disclosure of relevant documents, enables thorough factual investigation, which is essential for technically complex or multi-patent disputes.

Proceedings in the Patents Court typically take 12 to 24 months from issue to trial, depending on complexity, with appeals to the Court of Appeal adding further time. Cost budgets for a fully contested Patents Court trial in a moderately complex case commonly range from £500,000 to well over £2 million per side, inclusive of solicitor, counsel and expert witness fees. The court’s willingness to award substantial costs against the losing party creates both a deterrent and an incentive structure that shapes settlement dynamics throughout.

When to Start in IPEC and Transfer, and Vice Versa

Transfers between IPEC and the Patents Court are possible and, in practice, are ordered where a case proves more (or less) complex than initially anticipated. Early indications suggest that rights-holders should consider starting in IPEC where the primary objective is an injunction and the quantum of damages is likely to fall within or near the IPEC damages cap. If disclosure reveals broader infringement or higher quantum than expected, an application to transfer to the Patents Court can be made. Conversely, defendants facing a disproportionate Patents Court action may apply for transfer down to IPEC if the claim value and complexity justify it.

EPO v UK Litigation: Coordinating Revocation, Oppositions and Enforcement

A patent owner or challenger operating in the United Kingdom rarely faces a purely domestic decision. Where the UK patent derives from a European patent granted by the EPO, the interplay between EPO opposition proceedings and UK court enforcement creates both opportunities and risks that demand careful coordination. Understanding how these parallel routes interact is essential for effective cross-border patent enforcement.

When to Oppose at the EPO Before or After UK Action

EPO opposition proceedings must be filed within nine months of grant of the European patent. A successful opposition results in revocation or amendment of the patent across all designated EPC contracting states, a powerful tool for defendants seeking to eliminate a patent threat in multiple jurisdictions simultaneously. The cost of filing an opposition at the EPO is substantially lower than initiating revocation proceedings in each national court individually.

However, EPO opposition cannot enforce a patent or obtain an injunction. For rights-holders, the EPO route is therefore a defensive tool (to pre-empt validity attacks) rather than an enforcement mechanism. Industry observers expect the tactical calculus to evolve in 2026: with UKIPO fees rising, challengers may increasingly prefer the EPO opposition route where the nine-month window remains open, because it offers a cost-efficient means of centrally attacking validity without incurring the higher UK procedural costs.

Timing is critical. If UK proceedings are issued while an EPO opposition is pending, the Patents Court has discretion to stay the UK action pending the EPO outcome, but it is not obliged to do so, and stays are not automatically granted. The court will weigh factors including the likely timeline of the EPO decision, the urgency of the UK enforcement claim, and the risk of inconsistent outcomes.

Cross-Border Enforcement Coordination

For multi-jurisdictional enforcement, the UK remains an attractive anchor jurisdiction because of the strength of its injunctive remedies and the global reputation of its patent judiciary. Coordinating a UK High Court action with parallel EPO proceedings (or proceedings before the Unified Patent Court, where applicable) requires careful sequencing. Key considerations include estoppel risks, where findings in one jurisdiction may influence or bind proceedings in another, and the practical need to align evidence, expert testimony and legal arguments across forums. The likely practical effect is that rights-holders will increasingly use the UK as the primary enforcement venue while maintaining EPO opposition as a complementary validity tool, or vice versa, depending on whether they are claimant or defendant.

Managing Patent Litigation Costs in 2026: Budgeting, Funding and Early Decisions

Effective cost management in UK patent litigation requires deliberate decisions at the earliest stages of a dispute, long before proceedings are issued. The 2026 UKIPO fee increases amplify the importance of managing patent litigation costs by raising the baseline expenditure for both prosecution and enforcement. The following tactical steps represent current best practice.

• Model damages before issuing proceedings. A credible damages estimate informs forum choice (IPEC vs Patents Court), shapes settlement expectations and determines whether third-party funding is viable.
• Narrow the claim set. Reducing the number of patents and claims in dispute limits disclosure obligations, shortens trial duration and, post-April 2026, reduces UKIPO excess claims and excess page fees for any related prosecution activity.
• Use staged proceedings where appropriate. Splitting liability and quantum (damages) into separate phases allows the parties to reassess settlement positions after the liability finding, potentially avoiding the cost of a full quantum trial.
• Build ADR triggers into the litigation plan. Mediation and early neutral evaluation by a technically qualified mediator or retired patent judge can resolve disputes at a fraction of the cost of a full trial. Courts increasingly expect parties to have engaged in ADR, and unreasonable refusal to mediate can attract adverse costs consequences.
• Issue protective letters. Where a defendant anticipates that a rights-holder may seek without-notice interim relief, filing a protective letter with the court ensures that the defendant’s position is before the judge at the earliest opportunity.

Funding Options: Insurance, Third-Party Funding and After-the-Event Cover

The UK patent litigation funding landscape has matured considerably. Third-party litigation funding, where a funder finances the claim in return for a share of any recovery, is well established for high-value Patents Court cases. After-the-event (ATE) insurance can cover the risk of an adverse costs order. For IPEC claims, the capped costs regime means that funding requirements are lower, but ATE insurance remains useful to protect against the residual costs exposure. Contingency or conditional fee arrangements (CFAs) with solicitors and counsel are also available, subject to regulatory requirements.

Tactical Steps to Preserve Remedies

Preserving the availability of interim injunctions and other urgent relief demands early preparation. Rights-holders should ensure that they can demonstrate: a credible threat of irreparable harm, a strong prima facie case on infringement and validity, and that the balance of convenience favours injunctive relief. Practical steps include retaining expert evidence at the pre-action stage, documenting the chain of title to the patent, and, where evidence destruction is a risk, applying promptly for an Anton Piller (search) order or a preservation of evidence order.

Patent Enforcement UK: Remedies, Injunctions, Damages and Cross-Border Measures

The remedies available in UK patent litigation remain among the most powerful in the world. Understanding the range of relief, and the proof points required to secure each remedy, is essential for both claimants seeking to maximise recovery and defendants seeking to limit exposure. The IP practice area in the UK benefits from decades of specialised judicial experience in fashioning appropriate remedies.

Patent Injunctions UK: Criteria and Timing

Final injunctions are the standard remedy following a finding of patent infringement. Both the Patents Court and IPEC have jurisdiction to grant final injunctions, and courts will ordinarily do so unless there are exceptional circumstances (such as where an injunction would be disproportionate or where the public interest militates against it). Interim (pre-trial) injunctions are available but require the applicant to satisfy the well-established criteria: a serious question to be tried, that damages would not be an adequate remedy, and that the balance of convenience favours granting the injunction. In patent cases, interim injunctions are relatively rare because of the technical complexity involved, but they are sought, and granted, in appropriate urgent cases.

Damages, Account of Profits and Practical Proof Tips

A successful claimant may elect between damages (compensation for loss caused by infringement) and an account of profits (disgorgement of the infringer’s profits attributable to the infringement). The election is made after the liability trial. Proving quantum requires detailed financial evidence, sales data, royalty benchmarks, lost-profit calculations or profit-and-loss attribution. Early engagement of a forensic accountant or damages expert is essential to build a credible quantum case. In cross-border patent enforcement scenarios, the court may also consider the scope for border measures (working with UK Border Force to detain infringing goods) and the enforcement of UK judgments abroad under applicable treaties and conventions.

Practical Checklist and Timeline for Rights-Holders and Defendants

The following action lists provide a structured timeline for both sides of a patent dispute, incorporating the procedural and cost realities of patent litigation UK in 2026.

Rights-Holder Checklist:

• 0–30 days: Conduct damages modelling; confirm patent validity and chain of title; select forum (IPEC or Patents Court); instruct expert witnesses; send letter before action.
• 30–180 days: Issue proceedings; apply for interim relief if urgency justified; serve evidence; engage with court-directed case management and ADR.
• 180+ days: Complete disclosure; prepare for trial; reassess settlement position after liability phase (if staged); execute enforcement of any judgment obtained.

Defendant Checklist:

• 0–30 days: Assess validity of patent asserted; consider EPO opposition (if within nine-month window); file protective letter if interim relief anticipated; instruct technical experts.
• 30–180 days: File defence and counterclaim (invalidity and/or non-infringement); comply with disclosure obligations; engage with ADR and case management.
• 180+ days: Prepare for trial; manage parallel EPO proceedings (if any); assess settlement economics in light of costs incurred.

Key 2026 Dates: UKIPO fee changes effective 1 April 2026, review all pending filings and renewals. EPO opposition window: nine months from grant (check each patent individually). IPEC multi-track: trial typically within 12 months of issue.

Conclusion and Recommended First Steps for Patent Litigation UK

The United Kingdom remains one of the world’s premier jurisdictions for patent litigation in 2026, with specialist courts, experienced judges and a robust remedies framework. The UKIPO fee increases effective 1 April 2026 have raised the stakes for cost management, making early forum-choice decisions, portfolio rationalisation and coordinated EPO/UK strategy more important than ever. Rights-holders and defendants alike should prioritise three actions: first, conduct a rigorous IPEC vs Patents Court assessment based on realistic damages modelling; second, audit patent portfolios to ensure renewal and prosecution spending aligns with enforcement value; and third, integrate EPO opposition timing into any cross-border patent enforcement plan.

Experienced UK-qualified patent litigation counsel can help navigate these decisions efficiently and preserve the full range of available remedies.

Sources

1. UKIPO – New fees from 1 April 2026 (GOV.UK)
2. Judiciary.uk, IPEC Guide (revised November 2024)
3. GOV.UK, Patents Court
4. Fieldfisher, UK IPO fee increases from April 2026
5. Edwin Coe, Call to file! Increase in UKIPO fees from 1 April 2026
6. Bristows, Patent Litigation
7. Practical Law / Thomson Reuters, Patent Litigation in the UK: Overview